4Thyroid and Endocrine Causes

FWhy the cochlea cares about the thyroid

The inner ear is one of the most metabolically demanding tissues in the body. Its hair cells and the stria vascularis that powers them consume oxygen and glucose at a relentless rate, and thyroid hormone is the master regulator of that metabolism. It is therefore unsurprising that disorders of the thyroid gland — both underactivity and overactivity — can disturb hearing and provoke tinnitus.

Thyroid hormone also has a direct developmental and maintenance role in the cochlea. Receptors for tri-iodothyronine are expressed in the developing organ of Corti, and congenital thyroid deficiency is a classic cause of sensorineural hearing loss. In the adult ear the relationship is subtler: chronic metabolic imbalance, rather than a single dramatic event, gradually erodes cochlear function and may unmask the phantom auditory perception we call tinnitus [2013].

THypothyroidism and the slow ear

In hypothyroidism the proposed pathways to tinnitus are several and likely additive. Reduced metabolic drive lowers cochlear energy supply; mucopolysaccharide deposition (the same myxoedematous change seen in the skin) may stiffen middle-ear and inner-ear structures; and the generalised slowing of neural conduction can blur central auditory processing. A community study of adults found that acquired hypothyroidism was associated with measurable hearing impairment, supporting a true cochlear effect rather than mere coincidence [2025].

The clinically useful point is that this tinnitus may be reversible. When the underlying disorder is the cause rather than a bystander, restoring euthyroidism with levothyroxine can quieten the tinnitus along with the other systemic symptoms. This is why a thyroid-stimulating hormone (TSH) measurement belongs in the work-up of unexplained tinnitus, particularly when fatigue, weight gain, cold intolerance or dry skin accompany it.

THyperthyroidism and the racing ear

At the opposite pole, thyrotoxicosis drives a hyperdynamic circulation. The increased cardiac output and widened pulse pressure can be transmitted to the cochlea, and patients sometimes describe a pulse-synchronous or rushing tinnitus that mirrors their palpitations. A large population analysis reported that low TSH levels — the biochemical signature of an overactive or over-replaced gland — were associated with annoying tinnitus, linking the hyperthyroid state to the symptom at scale [2021].

Heightened sympathetic tone is a second mechanism. The same adrenergic surplus that produces tremor and anxiety amplifies the limbic and autonomic reaction to tinnitus, so a faint phantom sound becomes intolerable. Treating the thyrotoxicosis — and the associated anxiety — often softens both the loudness and the distress.

CThe autoimmune overlap

Much adult thyroid disease is autoimmune: Hashimoto thyroiditis and Graves disease. This matters for the ear because autoimmunity rarely respects organ boundaries. The same predisposition that attacks the thyroid can target the inner ear, and patients with autoimmune thyroid disease have an increased burden of audiovestibular symptoms. In a patient with fluctuating sensorineural hearing loss, tinnitus and positive thyroid antibodies, the clinician should think beyond simple metabolic effects and consider an autoimmune inner-ear process that may itself be steroid-responsive (covered in the autoimmune module).

The practical synthesis for the clinician is a three-part model: a metabolic effect (energy and conduction), a vascular effect (perfusion and pulsatility), and an autoimmune effect (shared immune targeting). Any of the three may dominate in a given patient, and the history — weight change, palpitations, fluctuation, family history of thyroid disease — points to which.

CTreating the gland to quieten the ear

The reward for recognising a thyroid cause is the prospect of cure rather than mere masking. Correcting hypothyroidism with levothyroxine, controlling thyrotoxicosis with antithyroid drugs, radio-iodine or surgery, and avoiding over-replacement that pushes the patient into iatrogenic hyperthyroidism are all interventions that can reduce tinnitus. Importantly, over-treatment matters: pushing TSH too low to suppress a nodule or goitre may trade one problem for tinnitus.

Set realistic expectations. The longer a metabolic derangement has injured the cochlea, the less completely the tinnitus will reverse; early correction gives the best chance. Even when residual tinnitus persists, addressing the thyroid removes one perpetuating factor and improves the general wellbeing on which tinnitus tolerance depends.